Cyramza Plus Lonsurf Did Not Improve Survival in Metastatic Colorectal Cancer
Cyramza plus Lonsurf did not significantly improve overall survival in heavily pretreated metastatic colorectal cancer patients compared to Lonsurf alone, according to the phase 3 IKF-AIO-RAMTAS trial. However, female patients and those with left-sided tumors showed potential benefit.
Reference News
Cyramza Plus Lonsurf Did Not Improve Survival in Metastatic Colorectal Cancer
Cyramza plus Lonsurf did not significantly improve overall survival in heavily pretreated metastatic colorectal cancer patients compared to Lonsurf alone, according to the phase 3 IKF-AIO-RAMTAS trial. However, female patients and those with left-sided tumors showed potential benefit.